Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m. ET, Teladoc stock was up 7%, but ...

Teladoc Health (NYSE:TDOC) is scheduled to announce Q2 results on Tuesday, July 29th, after market close, and investor focus will be on the details behind usual numbers—especially segment trends, ...

Teladoc's shares recently jumped after Citron Research, an online investment newsletter, claimed the market is not fairly valuing the telehealth company given its increasing free cash flow ...

Teladoc has consistently reported significant losses over the past years. As of Sept. 30, 2024, the company’s accumulated deficit reached $16.2 billion, up from $15.2 billion at the end of 2023.

Prominent short seller Andrew Left, the founder of Citron Research, has been charged by the U.S. Department of Justice with multiple counts of securities fraud for a $16 million stock market ...

Live Updates Live Coverage Has Ended 'Under-the-Radar' AI Play 2:57 pm by Gerelyn Terzo Citron Research has come out touting Teladoc Health (Nasdaq: TDOC) as an “under-the-radar” AI stock ...

Shares of Teladoc Health jumped 27.46 percent week-on-week to end at $12.95 apiece on Friday as investor sentiment was boosted by an analyst’s bullish outlook for the company following its ...